Table 5: Subgroups for Tdap and zoster vaccines.

 

Tdap

Zoster

Subgroups

Baseline
(N = 113,233)

Follow-up
(N = 107,503)

Baseline
(N = 44,800)

Follow-up
(N = 44,495)

Age (years)

 

 

 

 

< 65 years

54,980/109,731 (50.1%)

67,781/108,372 (62.5%)

4,575/14,558 (31.4%)

6,517/17,167 (38.0%)

65 - 80 years

16,530/36,109 (45.8%)

18,410/34,172 (53.9%)

10,453/35,295 (29.6%)

12,208/32,918 (37.1%)

> 80 years

2,522/8,049 (31.3%)

2,553/6,600 (38.7%)

1,463/7,863 (18.6%)

1,569/6,320 (24.8%)

Sex

 

 

 

 

Female

43,967/92,599 (47.5%)

53,759/90,502 (59.4%)

9,612/34,496 (27.9%)

11,985/33,784 (35.5%)

Male

30,065/61,290 (49.1%)

34,985/58,642 (59.7%)

6,879/23,220 (29.6%)

8,309/22,621 (36.7%)

Race

 

 

 

 

White

48,665/100,769 (48.3%)

57,659/97,249 (59.3%)

13,315/41,993 (31.7%)

16,207/40,826 (39.7%)

Black or African American

18,283/38,046 (48.1%)

22,756/37,955 (60.0%)

2,345/12,440 (18.9%)

3,103/12,514 (24.8%)

Asian/Pacific Islander

2,761/5,207 (53.0%)

3,783/5,970 (63.4%)

336/1,156 (29.1%)

456/1,277 (35.7%)

Other, reported

2,588/5,704 (45.4%)

2,529/4,322 (58.5%)

261/1,139 (22.9%)

240/894 (26.8%)

Insurance

 

 

 

 

Government

17,816/41,755 (42.7%)

23,005/43,722 (52.6%)

8,989/33,121 (27.1%)

11,848/34,292 (34.6%)

Private

49,307/95,817 (51.5%)

56,587/88,595 (63.9%)

5,100/14,677 (34.7%)

5,665/13,515 (41.9%)

Multiple

6,007/13,343 (45.0%)

7,816/13,901 (56.2%)

2,378/9,536 (24.9%)

2,745/8,237 (33.3%)

None

902/2,974 (30.3%)

1,336/2,926 (45.7%)

24/382 (6.3%)

36/361 (10.0%)

Cancer history

 

 

 

 

Yes

9,020/18,566 (48.6%)

10,644/18,394 (57.9%)

3,975/13,037 (30.5%)

4,960/12,477 (39.8%)

No

65,012/135,323 (48.0%)

78,100/130,750 (59.7%)

12,516/44,679 (28.0%)

15,334/43,928 (34.9%)

Diabetes

 

 

 

 

Yes

11,411/23,666 (48.2%)

13,288/22,694 (58.6%)

3,474/13,951 (24.9%)

4,269/13,263 (32.2%)

No

62,621/130,223 (48.1%)

75,456/126,450 (59.7%)

13,017/43,765 (29.7%)

16,025/43,142 (37.1%)

Chronic lung disease

 

 

 

 

Yes

5,325/10,608 (50.2%)

6,759/11,336 (59.6%)

1,456/5,728 (25.4%)

1,929/5,885 (32.8%)

No

68,707/143,281 (48.0%)

81,985/137,808 (59.5%)

15,035/51,988 (28.9%)

18,365/50,520 (36.4%)